Novo Nordisk to Stop Insulin Sales in Greece
Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices.
More than 50,000 Greeks with diabetes use Novo Nordisk’s insulin pen products.
Cross-posted on ASweetLife.
Recommended Stories
Comments
Follow Us
-
Follow us on twitter@thefastertimes
Most Popular
-
1
Amanda Bynes’s Behavior Revealed to Be Elaborate PSA
-
2
Obama Horrified by the Grammar in Our Emails
-
3
Incidental Boob Graze Redeems Trust Fall Exercise
-
4
Monster Fart Prompting Management to Rethink “Open Office”
-
5
NSA Demanded Access To Un-Filtered Instagram Photos
-
6
Dwayne ‘The Rock’ Johnson Ambushed By Alan ‘The Paper’ Rubinstein
-
7
Local Bully: Gay Boy Scouts a Dream Come True
-
8
‘Licensed to Kim Jong Il’ Records 27th Straight Year Atop N. Korean Charts
-
9
‘A/S/L’ Most Asked Question At Kaplan Online University Reunion
-
10
Stanley Cup Final One Blowout Away From “Boston Massacre” Headline Outrage
